First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas—a single-centre experience ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-01-04

AUTHORS

T. Brezina, H. von Dewitz, T. Schroeder, S. Ullrich, K. Nachtkamp, G. Reifenberger, B. Malzkorn, M. Sabel, R. Haas, G. Kobbe

ABSTRACT

Primary central nervous system non-Hodgkin lymphomas (PCNS-NHLs) are extranodal B-cell lymphomas with poor prognosis. The role of high-dose therapy (HDT) followed by autologous blood stem cell transplantation (ASCT) as first-line therapy is still not clear. We retrospectively collected long-term follow up data of 61 consecutive patients with PCNS-NHL at the University Hospital Düsseldorf from January 2004 to December 2016. Thirty-six patients were treated with conventional chemoimmunotherapy (cCIT) only (CT-group). Seventeen patients received an induction cCIT followed by HDT and ASCT. In the CT-group, the overall response rate (ORR) was 61% (CR 47%, PR 14%), and there were 8% treatment-related deaths (TRD). Progression-free survival (PFS) was 31.8 months, and overall survival (OS) was 57.3 months. In the HDT-group, the ORR was 88% (59% CR, 29% PR), and there were 6% TRD. Median PFS and OS were not reached at 5 years. The 5-year PFS and OS were 64.7%. After a median follow up of 71 months, 10 patients (59%) were still alive in CR/PR following HDT and ASCT, one patient was treated for progressive disease (PD), and 7 had died (41%, 6 PD, 1 TRD). All patients achieving CR prior to HDT achieved durable CR. In the CT-group, 8 patients (22%) were alive in CR/PR after a median follow-up of 100 months. Twenty-eight patients died (78%, 24 PD, 2 TRD, 2 deaths in remission). In the univariate analysis, the HDT-group patients had significantly better PFS (not reached vs 31.8 months, p = 0.004) and OS (not reached vs 57.3 months, p = 0.021). The multivariate analysis showed HDT was not predictive for survival. Treatment with HDT + ASCT is feasible and offers the chance for long-term survival with low treatment-related mortality in younger patients. In this analysis, ORR, PFS and OS were better with HDT than with conventional cCIT alone. This result was not confirmed in the multivariate analysis, and further studies need to be done to examine the role of HDT in PCNSL. More... »

PAGES

607-616

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-021-04745-z

DOI

http://dx.doi.org/10.1007/s00277-021-04745-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1144399179

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34982196


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Central Nervous System Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, Non-Hodgkin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Progression-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Autologous", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Oncology, University Hospital Zuerich, Zuerich, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.412004.3", 
          "name": [
            "Department of Oncology, University Hospital Zuerich, Zuerich, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brezina", 
        "givenName": "T.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine A, Hospital Merheim, Cologne, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine A, Hospital Merheim, Cologne, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Dewitz", 
        "givenName": "H.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schroeder", 
        "givenName": "T.", 
        "id": "sg:person.01271136615.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Life Science Center for Statistics, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Life Science Center for Statistics, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ullrich", 
        "givenName": "S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nachtkamp", 
        "givenName": "K.", 
        "id": "sg:person.01367010764.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367010764.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neuropathology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Neuropathology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reifenberger", 
        "givenName": "G.", 
        "id": "sg:person.07524506162.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07524506162.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neuropathology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Neuropathology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Malzkorn", 
        "givenName": "B.", 
        "id": "sg:person.01260604627.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260604627.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Neurosurgery, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sabel", 
        "givenName": "M.", 
        "id": "sg:person.0603244331.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603244331.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haas", 
        "givenName": "R.", 
        "id": "sg:person.01127414674.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobbe", 
        "givenName": "G.", 
        "id": "sg:person.01164073234.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2022-01-04", 
    "datePublishedReg": "2022-01-04", 
    "description": "Primary central nervous system non-Hodgkin lymphomas (PCNS-NHLs) are extranodal B-cell lymphomas with poor prognosis. The role of high-dose therapy (HDT) followed by autologous blood stem cell transplantation (ASCT) as first-line therapy is still not clear. We retrospectively collected long-term follow up data of 61 consecutive patients with PCNS-NHL at the University Hospital D\u00fcsseldorf from January 2004 to December 2016. Thirty-six patients were treated with conventional chemoimmunotherapy (cCIT) only (CT-group). Seventeen patients received an induction cCIT followed by HDT and ASCT. In the CT-group, the overall response rate (ORR) was 61% (CR 47%, PR 14%), and there were 8% treatment-related deaths (TRD). Progression-free survival (PFS) was 31.8\u00a0months, and overall survival (OS) was 57.3\u00a0months. In the HDT-group, the ORR was 88% (59% CR, 29% PR), and there were 6% TRD. Median PFS and OS were not reached at 5\u00a0years. The 5-year PFS and OS were 64.7%. After a median follow up of 71\u00a0months, 10 patients (59%) were still alive in CR/PR following HDT and ASCT, one patient was treated for progressive disease (PD), and 7 had died (41%, 6 PD, 1 TRD). All patients achieving CR prior to HDT achieved durable CR.\u00a0In the CT-group, 8 patients (22%) were alive in CR/PR after a median follow-up of 100\u00a0months. Twenty-eight patients died (78%, 24 PD, 2 TRD, 2 deaths in remission). In the univariate analysis, the HDT-group patients had significantly better PFS (not reached vs 31.8\u00a0months, p\u2009=\u20090.004) and OS (not reached vs 57.3\u00a0months, p\u2009=\u20090.021). The multivariate analysis showed HDT was not predictive for survival. Treatment with HDT\u2009+\u2009ASCT is feasible and offers the chance for long-term survival with low treatment-related mortality in younger patients. In this analysis, ORR, PFS and OS were better with HDT than with conventional cCIT alone. This result was not confirmed in the multivariate analysis, and further studies need to be done to examine the role of HDT in PCNSL.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-021-04745-z", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "101"
      }
    ], 
    "keywords": [
      "autologous blood stem cell transplantation", 
      "high-dose therapy", 
      "progression-free survival", 
      "overall response rate", 
      "treatment-related deaths", 
      "Primary central nervous system non-Hodgkin lymphoma", 
      "blood stem cell transplantation", 
      "overall survival", 
      "stem cell transplantation", 
      "CR/PR", 
      "conventional chemoimmunotherapy", 
      "non-Hodgkin lymphoma", 
      "progressive disease", 
      "cell transplantation", 
      "CT group", 
      "role of HDT", 
      "first-line high-dose therapy", 
      "multivariate analysis", 
      "median progression-free survival", 
      "low treatment-related mortality", 
      "better progression-free survival", 
      "extranodal B-cell lymphoma", 
      "treatment-related mortality", 
      "first-line therapy", 
      "single-center experience", 
      "long-term follow", 
      "University Hospital D\u00fcsseldorf", 
      "B-cell lymphoma", 
      "long-term survival", 
      "median follow", 
      "younger patients", 
      "consecutive patients", 
      "durable CR", 
      "poor prognosis", 
      "univariate analysis", 
      "patients", 
      "response rate", 
      "lymphoma", 
      "therapy", 
      "months", 
      "survival", 
      "Further studies", 
      "transplantation", 
      "follow", 
      "chemoimmunotherapy", 
      "prognosis", 
      "PCNSL", 
      "mortality", 
      "disease", 
      "death", 
      "treatment", 
      "role", 
      "years", 
      "PR", 
      "analysis", 
      "study", 
      "chance", 
      "rate", 
      "D\u00fcsseldorf", 
      "experience", 
      "data", 
      "results", 
      "Cr"
    ], 
    "name": "First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas\u2014a single-centre experience in 61 patients", 
    "pagination": "607-616", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1144399179"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-021-04745-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34982196"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-021-04745-z", 
      "https://app.dimensions.ai/details/publication/pub.1144399179"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_945.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-021-04745-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-021-04745-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-021-04745-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-021-04745-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-021-04745-z'


 

This table displays all metadata directly associated to this object as RDF triples.

245 TRIPLES      20 PREDICATES      100 URIs      92 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-021-04745-z schema:about N1a4952a11bca415a96f8a3b01764a6d9
2 N394e85bc90524c7dba13dd9ff28dd9d1
3 N4bea27392daa42cab750a1f66c7c6026
4 N646d06cbfacb4b6c8277cda3e0b5781e
5 N6a36e0db59cd4af5a65ffc7c93fa1891
6 N7d55f5ae70784a0288d3b40236799b02
7 N847fc4da0a57431a856f46985c2023df
8 N92d1b7c91cb24e9f993e27bd135d1394
9 Nb2c0a669003a49f2abadf00546b6f789
10 Nb985a0d74bdb46228c9969c52a4404bd
11 Nf945bcaf487f4395b9a12201d3fc669a
12 Nfc803f945d3f4dd9a73427e1f2e95134
13 anzsrc-for:11
14 anzsrc-for:1102
15 schema:author N3a33530f7157405c88280354ae110f7d
16 schema:datePublished 2022-01-04
17 schema:datePublishedReg 2022-01-04
18 schema:description Primary central nervous system non-Hodgkin lymphomas (PCNS-NHLs) are extranodal B-cell lymphomas with poor prognosis. The role of high-dose therapy (HDT) followed by autologous blood stem cell transplantation (ASCT) as first-line therapy is still not clear. We retrospectively collected long-term follow up data of 61 consecutive patients with PCNS-NHL at the University Hospital Düsseldorf from January 2004 to December 2016. Thirty-six patients were treated with conventional chemoimmunotherapy (cCIT) only (CT-group). Seventeen patients received an induction cCIT followed by HDT and ASCT. In the CT-group, the overall response rate (ORR) was 61% (CR 47%, PR 14%), and there were 8% treatment-related deaths (TRD). Progression-free survival (PFS) was 31.8 months, and overall survival (OS) was 57.3 months. In the HDT-group, the ORR was 88% (59% CR, 29% PR), and there were 6% TRD. Median PFS and OS were not reached at 5 years. The 5-year PFS and OS were 64.7%. After a median follow up of 71 months, 10 patients (59%) were still alive in CR/PR following HDT and ASCT, one patient was treated for progressive disease (PD), and 7 had died (41%, 6 PD, 1 TRD). All patients achieving CR prior to HDT achieved durable CR. In the CT-group, 8 patients (22%) were alive in CR/PR after a median follow-up of 100 months. Twenty-eight patients died (78%, 24 PD, 2 TRD, 2 deaths in remission). In the univariate analysis, the HDT-group patients had significantly better PFS (not reached vs 31.8 months, p = 0.004) and OS (not reached vs 57.3 months, p = 0.021). The multivariate analysis showed HDT was not predictive for survival. Treatment with HDT + ASCT is feasible and offers the chance for long-term survival with low treatment-related mortality in younger patients. In this analysis, ORR, PFS and OS were better with HDT than with conventional cCIT alone. This result was not confirmed in the multivariate analysis, and further studies need to be done to examine the role of HDT in PCNSL.
19 schema:genre article
20 schema:isAccessibleForFree true
21 schema:isPartOf N9a48c558604f46aa85d45c87d75f62a1
22 Ndb7efcd361a747bf9a0d852302a032e3
23 sg:journal.1358129
24 schema:keywords B-cell lymphoma
25 CR/PR
26 CT group
27 Cr
28 Düsseldorf
29 Further studies
30 PCNSL
31 PR
32 Primary central nervous system non-Hodgkin lymphoma
33 University Hospital Düsseldorf
34 analysis
35 autologous blood stem cell transplantation
36 better progression-free survival
37 blood stem cell transplantation
38 cell transplantation
39 chance
40 chemoimmunotherapy
41 consecutive patients
42 conventional chemoimmunotherapy
43 data
44 death
45 disease
46 durable CR
47 experience
48 extranodal B-cell lymphoma
49 first-line high-dose therapy
50 first-line therapy
51 follow
52 high-dose therapy
53 long-term follow
54 long-term survival
55 low treatment-related mortality
56 lymphoma
57 median follow
58 median progression-free survival
59 months
60 mortality
61 multivariate analysis
62 non-Hodgkin lymphoma
63 overall response rate
64 overall survival
65 patients
66 poor prognosis
67 prognosis
68 progression-free survival
69 progressive disease
70 rate
71 response rate
72 results
73 role
74 role of HDT
75 single-center experience
76 stem cell transplantation
77 study
78 survival
79 therapy
80 transplantation
81 treatment
82 treatment-related deaths
83 treatment-related mortality
84 univariate analysis
85 years
86 younger patients
87 schema:name First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas—a single-centre experience in 61 patients
88 schema:pagination 607-616
89 schema:productId N1e4bbc82753c47c2bbb29aea980f575b
90 N3a9ef4f569784c2fb419f7587ab4eaf1
91 Nd918027404b9486d8edc672bc06ac26f
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1144399179
93 https://doi.org/10.1007/s00277-021-04745-z
94 schema:sdDatePublished 2022-08-04T17:13
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher Nef20b10f8d534c3690d2404c7adefc6f
97 schema:url https://doi.org/10.1007/s00277-021-04745-z
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N1a4952a11bca415a96f8a3b01764a6d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Progression-Free Survival
103 rdf:type schema:DefinedTerm
104 N1c03fde1a2ee40859569822b0e1fbea3 rdf:first N6fba7fa8a51946af89a5be9fa6ee0876
105 rdf:rest N275bd336096e44338b8086d0f15bc8fc
106 N1e4bbc82753c47c2bbb29aea980f575b schema:name pubmed_id
107 schema:value 34982196
108 rdf:type schema:PropertyValue
109 N21b2cc4c3e1940cda5dfa01938980c78 rdf:first sg:person.07524506162.54
110 rdf:rest N4927501fe0cf4070befa5ff9835fc019
111 N275bd336096e44338b8086d0f15bc8fc rdf:first sg:person.01367010764.53
112 rdf:rest N21b2cc4c3e1940cda5dfa01938980c78
113 N394e85bc90524c7dba13dd9ff28dd9d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Antineoplastic Combined Chemotherapy Protocols
115 rdf:type schema:DefinedTerm
116 N3a33530f7157405c88280354ae110f7d rdf:first Nde5c6d9bf7f348fc940c5059fb190f8b
117 rdf:rest Nc85c940cc21142da97c59c63ac66f9d9
118 N3a9ef4f569784c2fb419f7587ab4eaf1 schema:name doi
119 schema:value 10.1007/s00277-021-04745-z
120 rdf:type schema:PropertyValue
121 N4927501fe0cf4070befa5ff9835fc019 rdf:first sg:person.01260604627.33
122 rdf:rest Nf322303e76f041bf9639252ee193307c
123 N4bea27392daa42cab750a1f66c7c6026 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Transplantation, Autologous
125 rdf:type schema:DefinedTerm
126 N646d06cbfacb4b6c8277cda3e0b5781e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Middle Aged
128 rdf:type schema:DefinedTerm
129 N695351801b334e41b17e2a594e6fb052 rdf:first sg:person.01127414674.14
130 rdf:rest N9f6556ad116c451ebb366fc0caaa35f0
131 N6a36e0db59cd4af5a65ffc7c93fa1891 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Hematopoietic Stem Cell Transplantation
133 rdf:type schema:DefinedTerm
134 N6fba7fa8a51946af89a5be9fa6ee0876 schema:affiliation grid-institutes:None
135 schema:familyName Ullrich
136 schema:givenName S.
137 rdf:type schema:Person
138 N7d55f5ae70784a0288d3b40236799b02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Aged
140 rdf:type schema:DefinedTerm
141 N80113f397f5f4f9cb62171059764233c rdf:first sg:person.01271136615.68
142 rdf:rest N1c03fde1a2ee40859569822b0e1fbea3
143 N847fc4da0a57431a856f46985c2023df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Humans
145 rdf:type schema:DefinedTerm
146 N869b7b50256c4850a28a7b83b554691a schema:affiliation grid-institutes:None
147 schema:familyName von Dewitz
148 schema:givenName H.
149 rdf:type schema:Person
150 N92d1b7c91cb24e9f993e27bd135d1394 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Female
152 rdf:type schema:DefinedTerm
153 N9a48c558604f46aa85d45c87d75f62a1 schema:issueNumber 3
154 rdf:type schema:PublicationIssue
155 N9f6556ad116c451ebb366fc0caaa35f0 rdf:first sg:person.01164073234.53
156 rdf:rest rdf:nil
157 Nb2c0a669003a49f2abadf00546b6f789 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Male
159 rdf:type schema:DefinedTerm
160 Nb985a0d74bdb46228c9969c52a4404bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Lymphoma, Non-Hodgkin
162 rdf:type schema:DefinedTerm
163 Nc85c940cc21142da97c59c63ac66f9d9 rdf:first N869b7b50256c4850a28a7b83b554691a
164 rdf:rest N80113f397f5f4f9cb62171059764233c
165 Nd918027404b9486d8edc672bc06ac26f schema:name dimensions_id
166 schema:value pub.1144399179
167 rdf:type schema:PropertyValue
168 Ndb7efcd361a747bf9a0d852302a032e3 schema:volumeNumber 101
169 rdf:type schema:PublicationVolume
170 Nde5c6d9bf7f348fc940c5059fb190f8b schema:affiliation grid-institutes:grid.412004.3
171 schema:familyName Brezina
172 schema:givenName T.
173 rdf:type schema:Person
174 Nef20b10f8d534c3690d2404c7adefc6f schema:name Springer Nature - SN SciGraph project
175 rdf:type schema:Organization
176 Nf322303e76f041bf9639252ee193307c rdf:first sg:person.0603244331.36
177 rdf:rest N695351801b334e41b17e2a594e6fb052
178 Nf945bcaf487f4395b9a12201d3fc669a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Retrospective Studies
180 rdf:type schema:DefinedTerm
181 Nfc803f945d3f4dd9a73427e1f2e95134 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Central Nervous System Neoplasms
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
188 schema:name Cardiorespiratory Medicine and Haematology
189 rdf:type schema:DefinedTerm
190 sg:journal.1358129 schema:issn 0939-5555
191 1432-0584
192 schema:name Annals of Hematology
193 schema:publisher Springer Nature
194 rdf:type schema:Periodical
195 sg:person.01127414674.14 schema:affiliation grid-institutes:grid.411327.2
196 schema:familyName Haas
197 schema:givenName R.
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14
199 rdf:type schema:Person
200 sg:person.01164073234.53 schema:affiliation grid-institutes:grid.411327.2
201 schema:familyName Kobbe
202 schema:givenName G.
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53
204 rdf:type schema:Person
205 sg:person.01260604627.33 schema:affiliation grid-institutes:grid.14778.3d
206 schema:familyName Malzkorn
207 schema:givenName B.
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260604627.33
209 rdf:type schema:Person
210 sg:person.01271136615.68 schema:affiliation grid-institutes:grid.411327.2
211 schema:familyName Schroeder
212 schema:givenName T.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68
214 rdf:type schema:Person
215 sg:person.01367010764.53 schema:affiliation grid-institutes:grid.411327.2
216 schema:familyName Nachtkamp
217 schema:givenName K.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367010764.53
219 rdf:type schema:Person
220 sg:person.0603244331.36 schema:affiliation grid-institutes:grid.14778.3d
221 schema:familyName Sabel
222 schema:givenName M.
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603244331.36
224 rdf:type schema:Person
225 sg:person.07524506162.54 schema:affiliation grid-institutes:grid.14778.3d
226 schema:familyName Reifenberger
227 schema:givenName G.
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07524506162.54
229 rdf:type schema:Person
230 grid-institutes:None schema:alternateName Department of Internal Medicine A, Hospital Merheim, Cologne, Germany
231 Life Science Center for Statistics, Duesseldorf, Germany
232 schema:name Department of Internal Medicine A, Hospital Merheim, Cologne, Germany
233 Life Science Center for Statistics, Duesseldorf, Germany
234 rdf:type schema:Organization
235 grid-institutes:grid.14778.3d schema:alternateName Department of Neuropathology, University Hospital Duesseldorf, Duesseldorf, Germany
236 Department of Neurosurgery, University Hospital Duesseldorf, Duesseldorf, Germany
237 schema:name Department of Neuropathology, University Hospital Duesseldorf, Duesseldorf, Germany
238 Department of Neurosurgery, University Hospital Duesseldorf, Duesseldorf, Germany
239 rdf:type schema:Organization
240 grid-institutes:grid.411327.2 schema:alternateName Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany
241 schema:name Department of Haematology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany
242 rdf:type schema:Organization
243 grid-institutes:grid.412004.3 schema:alternateName Department of Oncology, University Hospital Zuerich, Zuerich, Switzerland
244 schema:name Department of Oncology, University Hospital Zuerich, Zuerich, Switzerland
245 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...